EntreMed, Inc. New (ENMD) Widens Q2 Loss to 56c/Share
Tweet
Share
E-mailGet Alerts ENMD Hot Sheet
Join SI Premium – FREE
EntreMed, Inc. New (NASDAQ: ENMD) reported Q2 EPS of ($0.56), versus ($0.17) reported last year.
For earnings history and earnings-related data on EntreMed, Inc. New (ENMD) click here.
For earnings history and earnings-related data on EntreMed, Inc. New (ENMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- 4D Molecular Therapeutics, Inc. (FDMT) Misses Q2 EPS by 3c
- Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
